Paneth and intestinal stem cells preserve their functional integrity during worsening of acute cellular rejection in small bowel transplantation by Pucci Molineris, Melisa Eliana et al.
A
cc
ep
te
d 
A
rt
ic
le
This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1111/ajt.14592 
This article is protected by copyright. All rights reserved. 
Article type      :  Brief Communication 
 
 
Paneth and Intestinal Stem Cells Preserve their Functional Integrity during Worsening 
of Acute Cellular Rejection in Small Bowel Transplantation 
 
M. Pucci Molineris1,2, V. Gonzalez Polo1,2, Federico Perez3, D. Ramisch2, M. Rumbo3, G. 
E. Gondolesi1,2 and D. Meier1,2* 
 
1Laboratorio de Investigación Traslacional e Inmunología Asociada al Trasplante, Instituto 
de Medicina Traslacional, Trasplante y Bioingeniería (IMeTTyB), Universidad Favaloro-
CONICET, Buenos Aires, Argentina 
2Instituto de Trasplante Multiórganico, Hospital Universitario Fundación Favaloro, Buenos 
Aires, Argentina 
3Instituto de Estudios Inmunológicos y Fisiopatológicos, UNLP-CONICET, La Plata, 
Argentina 
 
*Corresponding author: 
Dominik Meier, dommeier@gmail.com 
 
Abbreviations: ACR, acute cellular rejection; BZ, bottom zone; CASP3, caspase 3; DEFA5, 
defensin alpha 5; GvHD, graft versus host disease; ILC3, innate lymphoid cell subpopulation 
3; IL22R, interleukin 22 receptor; ISC, intestinal stem cells; ITx, intestinal transplantation; 
MR, mild ACR; MoR, moderate ACR; ROS, reactive oxygen species; SR, severe ACR; TAC, 
tacrolimus; TZ, transit-amplifying zone 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Abstract 
Graft survival after small bowel transplantation remains impaired due to acute cellular 
rejection (ACR), the leading cause of graft loss. Although it was shown that the number of 
enteroendocrine progenitor cells in intestinal crypts was reduced during mild ACR, no results 
of Paneth and intestinal stem cells localized at the crypt bottom have been shown so far. 
Therefore, we wanted to elucidate integrity and functionality of the Paneth and stem cells 
during different degrees of ACR, and to assess whether these cells are the primary targets 
of the rejection process. We compared biopsies from ITx patients with no, mild or moderate 
ACR by immunohistochemistry and quantitative PCR. Our results show that numbers of 
Paneth and stem cells remain constant in all study groups, whereas the transit-amplifying 
zone is the most impaired zone during ACR. We detected an unchanged level of 
antimicrobial peptides in Paneth cells and similar numbers of Ki-67+ IL-22R+ stem cells 
revealing cell functionality in moderate ACR samples. We conclude that Paneth and stem 
cells are not primary target cells during ACR. IL-22R+ Ki-67+ stem cells might be an 
interesting target cell population for protection and regeneration of the epithelial monolayer 
during/after a severe ACR in ITx patients. 
 
Introduction 
Intestinal transplantation (ITx) is the ultimate medical alternative for patients with life-
threatening intestinal failure and complications of parenteral nutrition (1,2). Although the 
incidence of acute cellular rejection (ACR) has decreased in recent years with new 
immunosuppressive protocols, ACR is still the main cause of graft loss or the recipient’s 
death (3,4). To diagnose ACR in the allograft of ITx patients, a well-accepted grading system 
has been developed (5,6). The histological criteria for mild ACR is: villus blunting and 
architectural distortion, mixed but primarily mononuclear inflammatory population including 
activated lymphocytes, eosinophils, and occasional neutrophils. For moderate ACR: crypt 
injury at a greater level, mixed but primarily mononuclear inflammatory population including 
activated lymphocytes, edema, vascular congestion, and villus blunting. For severe ACR: 
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marked degree of crypt damage, presence of ulceration, marked inflammatory infiltrate with 
activated lymphocytes, eosinophils, and neutrophils (6). One important feature of this 
grading schema is the count of apoptotic bodies in crypt epithelium. The crypts of 
Lieberkühn are composed of two main parts, the transit-amplifying zone (TZ) harboring cells 
that are in active proliferation until their cell specific differentiation, and the bottom zone (BZ) 
at the crypt base containing intestinal stem cells (ISC) and Paneth cells (7). Intestinal stem 
cells are responsible for the constant regeneration of the epithelial layer and reconstitution 
when injured (8), whereas Paneth cells express their function mainly in producing anti-
microbial peptides (9,10). The importance of Paneth cells regulating human gut microflora 
has been reported in several studies on patients with Crohn’s disease (11-13). In these 
studies, a decrease of defensin alpha 5 (DEFA5) expression resulted in a gut microbiota 
imbalance generating further inflammatory responses.  
Interestingly, it has been shown in mouse models of graft versus host disease (GvHD) that 
the ISC and Paneth cells are target cells and do not recover during GvHD pathogenesis (14-
16). The study by Hanash et al. (15) highlights a protective role of IL-22 for ISC during the 
intestinal inflammatory damage provoked by GvHD mechanisms. The importance of the IL-
22/ IL-22 receptor axis for ISC has further been revealed in a study of patients with GvHD 
after hematopoietic stem cell transplantation (17). The authors analyzed the IL-22-producing 
innate lymphoid cell subpopulation 3 (ILC3) in the peripheral blood of these patients and 
found correlation between a higher number of activated ILC3 and a better protection from 
GvHD. A fundamental role of IL-22 for the expansion and proliferation of IL-22R positive ISC 
has also been shown in experiments with mice and human intestinal ex vivo organoids (18). 
So far, no studies about ISC and the IL-22R have been conducted in the ITx field. Fishbein 
et al. (19) contributed with a study showing diminished number of endocrine cells and their 
progenitors in crypts of ITx patients with mild ACR. We wanted to go a step further and 
studied, which are the primary target cells and whether number and functionality of Paneth 
cells and ISC are affected during worsening of the ACR process. 
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Materials and Methods 
Patients 
The present protocol was approved by the Institutional Review Board of Hospital 
Universitario Fundacion Favaloro (DDI (1125) 511). Patients with intestinal transplantation 
from 2006 to 2016 were enrolled in this study. Details of ITx surgical procedures, 
immunosuppressive therapy, and patients’ follow-up care were previously reported (20-22). 
Detailed patients’ data are shown in Table 1. Six to 8 biopsies were obtained from the distal 
ileum and divided randomly, 3-5 biopsies for histological diagnosis and 2-3 biopsies for 
qPCR analysis. Our study groups were: No rejection (N; without any signs of 
histopathological and significant clinical symptoms 72 h before endoscopy, such as 
abdominal pain, self-limited diarrhea/increased ostomy output, respiratory symptoms or 
episodes of isolated fever), mild ACR (MR; with histological evidence of mild ACR), 
moderate ACR (MoR), and severe ACR (SR). Our inclusion criteria for N, MR, and MoR 
biopsies of this retrospective study were: 1. Biopsies unequivocally diagnosed by an 
experienced pathologist in accordance with the recommendations of the pathology workshop 
of the VIII Small Bowel Transplantation Symposium (6); 2. At least two previous biopsies 
and two months without histopathological and clinical events; 3. First appearance of MR and 
MoR events; 4. Patients without any additional treatment. Biopsies with SR (with ulceration) 
were only selected based on histopathological diagnosis, as these biopsies were not fulfilling 
the other stringent inclusion criteria. For gene expression analysis, we included ileum 
biopsies from healthy volunteers (control group, C), which were endoscopically evaluated for 
colon cancer, for sample normalization considering changes associated with the complex 
immunological status of the graft. We did not detect differences between pediatrics and 
adults; therefore, we pooled both age groups in our analyses. 
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Immunohistochemistry 
Paraffin-embedded intestinal biopsies were used. Tissue sections were deparaffinized 
following standard procedures as previously described (23). Antibodies enrolled in this study 
are listed in Table 2. 
 
Procedure of cell counting in small bowel tissue biopsies 
The number of Paneth cells, IL22R+ ISC, Ki67+ ISC and apoptotic bodies were determined 
by examination of immunostained whole tissue specimens from 3-5 biopsies/patient. After 
the staining procedure, a research group member took pictures of all crypts in the slide and 
then another scientist, who was unaware of the histopathological conditions of the crypts, 
performed cell counting in a blind manner. Crypts were divided in two zones. The zone with 
DEFA5+ Paneth cells was defined as the bottom zone (BZ), whereas the zone localized 
upstream as transit-amplifying zone (TZ) (Figure S1). Numbers of apoptotic bodies per 
zone/10 crypts were recorded. We defined IL22R+ or Ki67+ cells, which were interspersed 
between DEFA5+ Paneth cells at the BZ, as ISC. Numbers of ISC/ 10 Paneth cell+ crypts 
were determined. 
 
Gene expression analysis 
The samples were taken by video endoscopy, immediately embedded in RNA later (Ambion, 
Austin, USA) and stored at -80°C for total RNA extraction. RNA extraction, cDNA synthesis 
and qPCR procedure were conducted as previously described (23). Evaluated genes and 
the corresponding primer pairs are listed in Table 2.  
 
Statistical analysis 
Comparisons among groups of data were performed with the Kruskal-Wallis test and the 
Dunn`s post-test when more than two groups were analyzed, whereas the Mann-Whitney U 
test was chosen to compare data from two groups. To evaluate the two zones of crypts from 
the same sample, a paired t test was used. All the statistical analyses were performed using 
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GraphPad Prism 5.01 software (San Diego, USA). Qualitative variables were analyzed with 
Chi-square test using IBM SPSS Statistics v23 software. 
 
 
Results 
Paneth cells are intact during episodes of acute cellular rejection in human allograft 
tissue 
To evaluate in the biopsy section whether Paneth cells and ISC are affected by apoptosis or 
losing their functionality, we first compared the number of DEFA5+ cells by 
immunohistochemistry between no-rejection, mild, moderate, and severe ACR. We detected 
DEFA5+ cells in all study groups (Figure 1A-D). The mean number of Paneth cells was 
minimally lower in MoR and SR than in MR samples. However, this difference was not 
statistically significant (Figure 1E). The dispersion in the SR group was due to 3 samples 
with severe exfoliative diagnosis and these samples revealed a reduced number of crypts 
and Paneth cells/ crypts. In addition, we show here that gene expression levels of two 
antimicrobial peptides DEFA5 and LYZ in MR and MoR samples are on a comparable level 
to healthy control samples (Figure 1F). Moreover, the DEFA5 expression level is slightly 
higher in MoR samples than in MR samples, whereas no significant difference of LYZ 
expression between both groups was detected. 
 
Transit-amplifying zone is more affected by apoptosis than the bottom of the crypts 
In traditional diagnostic method, apoptotic bodies are counted in slides with hematoxylin and 
eosin staining without distinguishing cell type or location in the crypts to indicate the grade of 
ACR (Figure 2A-C). We used an anti-CASP3 antibody as an apoptotic marker to determine 
which crypt zone apoptosis is predominant in and whether DEFA5+ Paneth cells co-express 
this marker. As we did not detect a reduction of DEFA5+ Paneth cells in our study groups, 
we used DEFA5+ Paneth cells to distinguish the BZ from TZ (Figure S1). Surprisingly, we 
could only determine CASP3+ apoptotic bodies and not CASP3+ intact cells (Figure 2E,F). 
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As we expected, we did not detect CASP3+ Paneth cells either in MR or in MoR samples. 
The mean number of CASP3+ apoptotic bodies in the BZ is slightly higher in MoR group than 
in MR and N groups, whereas, we detected a statistically significant difference of the mean 
number in the TZ from MoR samples than N samples (Figure 2G). In addition, the mean 
number of CASP3+ apoptotic bodies was significantly higher in the TZ than in the BZ from 
MoR samples (Figure 2G). 
 
Intestinal stem cells are not affected during early stages of acute cellular rejection 
Next, we wanted to determine the status of ISC during the ACR process. As ISC express the 
IL-22 receptor (IL22R), we used an anti-IL22R antibody to detect ISC and the anti-DEFA5 
antibody to distinguish the Paneth cells from the ISC by immunohistology. We could hardly 
identify a co-localization of IL22R and DEFA5 in Paneth cells, whereas single positive IL22R 
cells beneath DEFA5+ cells were frequently observed (Figure 3A). We identified IL22R+ ISC 
in all study groups (Figure 3A-D). There were no statistically significant differences among 
study groups in term of the number of IL22R+ ISC per Paneth cells positive crypt (Figure 3E). 
Regarding the gene expression of IL22RA1, no statistically significant difference could be 
determined between no rejection and MoR groups (Figure 3F). We used three different anti-
LGR5 antibodies to identify ISC, but we didn’t detect LGR5+ ISC by immunohistochemistry in 
human small bowel tissue from the distal part (data not shown). Therefore, we measured 
LGR5 gene expression level in no rejection and MoR samples and revealed that expression 
level was comparable and not even reduced in comparison to the normal control group of no 
Tx samples (Figure 3F). 
 
Proliferation of intestinal stem cells is not hindered during acute cellular rejection 
The renewal of intestinal epithelium involves the continuous proliferation of ISC in the crypt 
base with subsequent migration of these cells to the luminal surface. After intestinal injury, 
epithelial regeneration is critical for barrier maintenance and organ function. To evaluate this 
proliferative ability of ISC in the context of ACR, we detected and counted Ki-67+ 
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proliferating cells that were interspersed between Paneth cells. We detected proliferative 
cells at the BZ in all analyzed biopsies independently of the severity of rejection (Figure 4A-
D). Although the number of Ki-67+ ISC per DEFA5+ crypts decreased significantly in SR 
compared to N and MR groups, there are still Ki-67+ ISC in all residual crypts of these 
severe cases detectable (Figure 4E). 
 
 
Discussion 
Paneth cells and ISC are affected in several inflammatory GI diseases, such as Crohn’s 
disease and GvHD after hematopoietic stem cell transplantation. In ITx, apoptotic bodies in 
the crypts have been identified as a key feature for the diagnosis of ACR. However, which 
cell type in the crypts is affected during worsening of ACR process has not been completely 
understood. Here, our results indicate that Paneth cells and ISC are not reduced in number, 
and both cell types retain their functionalities ranging from mild to moderate and severe ACR 
events in biopsies of ITx patients - suggesting that the bottom of the crypt is not the initial 
target site of the ACR process. In addition, we show that the TZ is more susceptible to 
apoptosis than the BZ considering the TZ as the primary target during the ACR process, 
whereas the BZ might be stimulated for tissue repair after the injury. 
 
Our results showing no reduction of Paneth cells during mild ACR are in line with 
unpublished results of the study by Fishbein et al. (19). We included two groups with more 
severe ACR features (more apoptotic bodies in the crypts, more infiltrating cells) in our 
analysis biopsies than the mild group. In MoR and SR groups, we detected an intrinsically 
slight reduction of Paneth cell numbers without statistical significance, whereas the level of 
DEFA5 gene expression was mildly increased in MoR samples. This increase of DEFA5 
gene expression in the MoR samples might be due to more intensive induction of 
antimicrobial peptide production compensating the loss of the epithelial integrity. However, 
the intact DEFA5+ Paneth cells in moderate and severe ACR cleared the way to use DEFA5 
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as a marker for the BZ in the crypt from biopsy sections. In biopsies with exfoliative 
diagnosis, a slight decrease in Paneth cells/crypts was detected. Exfoliative rejection is a 
highly aggressive form of severe ACR where a complete loss of villi and a critical loss of the 
integrity of whole crypts is one of its characteristics. However, the residual crypts might be 
responsible for the complete tissue regeneration and mucosal recovery. It would be 
interesting to investigate these crypts in more details to identify genes involved in tissue 
regeneration after ACR process.  
We used anti-IL-22R antibody to identify ISC localized at the crypt bottom and beneath 
Paneth cells. No reduction of ISC was detected in the mild and moderate ACR compared to 
the no-rejection group. Several studies in mice suggested that in the crypt bottom, two 
different types of intestinal stem cells might be present, a quiescent and a proliferation type 
(24,25). We confirmed with the proliferation marker Ki-67 that proliferating ISC are present 
beneath Paneth cells in the crypt bottom. Strikingly, we could still detect these proliferating 
ISC in biopsies with moderate and severe ACR suggesting that these cells are not the target 
cells and are not losing their functionality.  
Interestingly, the intact architecture of the crypt bottom during mild, moderate and severe 
ACR is almost the opposite that what has been reported so far in the scenery of GvHD from 
patients undergoing hematopoietic stem cell transplantation or GvHD mouse models. In a 
series of GvHD patients at our institution (data not shown), as well as in these reports, 
Paneth cells and ISC are the primary target cells and their functionality are highly affected 
(14,26,27). However, the differences in these studies are first, the morphological site, where 
in ITx we strictly compared distal ileum biopsies whereas in the human GvHD, duodenal 
biopsies have been studied (26). Whether the different site has an influence of target cells 
has still to be evaluated. Second, the high-dose chemoradiotherapy that is used for a pre-
transplant conditioning for hematopoietic stem cell transplantation damages the GI tract 
initially and plays a central role in amplifying GVHD (28). ITx has not such a preconditioning 
step. Third, although the underlying principle of alloimmunity might be similar in both 
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transplants, details on cellular and molecular level may differ and even be decisive for the 
primary target cells.  
The classical mechanism of ACR is that cytotoxic T cells recognize alloantigens presented 
by donor epithelial cells and consequently induce apoptosis in target cells (1). Apoptosis 
goes through a well-defined mechanism including a cascade of activation of different 
protease enzymes, mainly caspases. Anti-CASP3 antibodies have been proposed as 
markers for apoptosis. Talmon et al. (29) showed not only CASP3 positive apoptotic bodies, 
but also CASP3 positive yet intact cells in the intestinal crypts. In our hands, we detected 
with the anti-CASP3 antibody only apoptotic bodies and not intact cells, consequently no co-
localization with specific Paneth cell and ISC markers was feasible. We also implemented 
M30, another marker for apoptosis, but we haven’t detected M30+ cells in the crypts of ITx 
biopsies from distal ileum, whereas we observed M30+ cells in colonic control tissues (data 
not shown). In an ischemia/reperfusion model co-localization of M30 or CASP3 with DEFA5 
was successfully documented (30). However, the underlined biological mechanisms are 
different in this model than in the ITx. We speculate that the whole process of induction and 
targeting cells during ACR is even more complex and that most probably the loss of the 
epithelial monolayer is not only due to alloreactive cells targeting crypt cells, but endothelial 
cells might be primarily targeted. 
 
In summary, our study shows that Paneth cells and ISC located at the bottom of crypts are 
neither the primary nor the main target site during initial ACR process in ITx patients. Paneth 
cells and ISC remain functionally active even during an advanced stage of ACR resulting as 
the driving cells for the repair process, whereas apoptotic cells are mainly localized in the TZ 
provoking a loss of crypt integrity being the main target site during ACR. Further 
investigation needs to be conducted in the field of IL22/IL22R axis concerning ITx. 
Stimulation of IL22R+ ISC might be a novel therapeutic option to accelerate mucosal 
regeneration after a severe ACR and to consequently protect the allograft of a potential 
complete loss or even loss of the patient through sepsis.  
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Figure Legends 
Figure 1: Paneth cells during ACR in ITx. Representative immunofluorescence detection 
of Paneth cells (DEFA5+, green) in ITx biopsies with (A) non-rejection (N); (B) mild rejection 
(MR); (C) moderate rejection (MoR); (D) severe rejection (SR). Magnification 400X. (E) 
Number of Paneth cells per DEFA5+ crypt in N (n = 13), MR (n = 9), MoR (n = 12), and SR 
(n = 6) groups. (F) Gene expression of DEFA5 and LYZ in N (n = 5) and MoR (n = 6) groups. 
Gene expression was normalized using b-actin gene as reference. Fold increase was 
calculated using the ∆∆Ct method using the average of the control (non-Tx) group as 
normalizer. The values are shown as mean ± SD and the groups were compared using 
Kruskal-Wallis test with Dunn`s post-test or one-tail Mann-Whitney U test as appropriate. 
 
Figure 2: Apoptosis in the different zone of intestinal crypts during ACR. Hematoxylin-
eosin staining from ITx biopsies with (A) non-rejection (N); (B) mild rejection (MR); (C) 
moderate rejection (MoR). Apoptotic bodies are indicated with black arrows. Magnification 
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400X. Immunofluorescence detection of cleaved caspase-3 (red; indicated by white arrows) 
and Paneth cells (DEFA5+; green) in ITx biopsies with (D) non-rejection (N); (F) mild 
rejection (MR); (E) moderate rejection (MoR). Magnification 400X. (G) Apoptosis number per 
ten crypts in the bottom (BZ) or transit-amplifying (TZ) zone. The values are shown as mean 
± SD. The groups were compared using Kruskal-Wallis test with Dunn`s post-test and the 
analysis of the zones was performed through a paired t-test.*P < 0.05.  
 
Figure 3: IL22R+ intestinal stem cells (ISC) in an ACR context. Immunohistochemical 
staining to IL22R (violet) and Paneth cells (brown) in ITx biopsies with (A) no rejection (N); 
(B) mild rejection (MR); (C) moderate rejection (MoR); (D) severe rejection (SR). 
Magnification 200X. IL22R+ cells interspersed between Paneth cells were considered as ISC 
(dotted line). (E) Number of IL22+ ISC per DEFA5+ crypt in N (n = 13), MR (n = 9), MoR (n = 
12), and SR (n = 5) groups. (F) Gene expression of IL22RA and LGR5 in N (n = 5) and MoR 
(n = 6) groups. Gene expression was normalized using b-actin gene as reference. Fold 
increase was calculated using the ∆∆Ct method using the average of the control (non-Tx) 
group as normalizer. The values are shown as mean ± SD and the groups were compared 
using Kruskal-Wallis test with Dunn`s post-test or one-tail Mann-Whitney U test as 
appropriate. 
 
Figure 4: Proliferative capability of intestinal stem cells. Immunofluorescence detection 
of Ki-67 (red) and Paneth cells (DEFA5+; green) in ITx biopsies with (A) non-rejection (N); 
(B) mild rejection (MR); (C) moderate rejection (MoR); (D) severe rejection (SR). 
Magnification 400X. Ki-67+ cells interspersed between Paneth cells were considered as 
proliferative ISC (white arrows). (E) Number of Ki-67+ ISC per DEFA5+ crypt in N (n = 13), 
MR (n = 7), MoR (n = 11), and SR (n = 5) groups. The values are shown as mean ± SD and 
the groups were compared using Kruskal-Wallis test with Dunn`s post-test. *P < 0.05. 
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Supporting Information 
Additional Supporting Information may be found in the online version of this article. 
 
Figure S1: Intestinal crypt. (A) Graphic representation of intestinal crypt. The bottom (BZ) 
and transit-amplifying (TZ) zone are morphologically defined. (B) Immunofluorescence 
images (DEFA5+, green; DAPI, blue) of a representative biopsie slide. The different 
orientations that crypts can adopt in the same section are indicated. Magnification 200X. 
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